Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,253 total articles
Mobileye combines broad OEM reach, recurring ADAS revenue and meaningful free cash flow to offer physical-AI exposure at a lower effective valuation and lower execution risk than many pure-sensor rivals. I recommend a tactical long with clearly defined entry, stop and targets over a mid-term horizon.
Sprout Social is trading well below its prior highs despite improving cash generation and a technical setup that favors a bounce. With management signaling a strong Q1 and free cash flow of roughly $46.7M, the stock looks oversold on AI-related narrative risk. This is a tactical long with a clear entry at $7.30, stop at $6.20 and a target of $12.00…
Pagaya has posted five consecutive profitable quarters, generated meaningful free cash flow and trades at modest multiples vs. growth peers. Yet about 23% of the float is short and short-volume remains high. This trade idea lays out a mid-term swing entry at $14.60 with a $20.00 target and a $12.00 stop, anchored to fundamentals, cash flow and a pl…
CACI is a core government‑services player with strong free cash flow, modest leverage, and improving technical momentum. We reaffirm Buy and lay out a clear swing trade: entry at $518.67, stop at $490, target $600 over the next 45 trading days, based on renewed federal contract wins and a favorable valuation versus growth profile.
Liberty Global (LBTYA) is trading at a steep discount to replacement-value and peers on headline multiples. With an enterprise value of roughly $10.7B against a market cap near $4.2B, EV/EBITDA around 9.4x and price/book ~0.43, the stock looks like a classic sum‑of‑the‑parts story. I put on a long trade at $12.30 with a $16.00 target and a $9.75 st…
Atea (AVIR) is a clinical-stage antiviral developer trading at a modest market cap with Phase 3 HCV programs advancing and an HEV program entering first-in-human studies. Given recent drug-drug interaction data and an improving clinical narrative, I favor a long trade into upcoming catalysts with a defined entry, stop and target — while acknowledgi…
Constellation Energy (CEG) looks like a compelling buy on a pullback: the stock is trading near the lower end of its 52-week range, the utility produces healthy free cash flow and balance-sheet metrics that can support contracts with large customers like data centers. We outline an actionable trade with entry, stop and target, plus the key risks an…
Snowflake delivered a clean earnings beat and linked a meaningful step-up in growth to AI adoption and a new $6B AWS commitment. The market has re-rated Snowflake aggressively this week, but fundamentals - 33% revenue growth, improving guidance, and $1.12B in free cash flow - argue there’s more upside. This trade idea buys the rally with a clear en…
Accelerant Holdings (ARX) has turned early momentum into measurable growth and its stock is carving a structurally bullish setup. Revenue and exchange-written premium jumped meaningfully in 2025 and technicals are confirming renewed demand. This trade idea lays out an actionable swing entry with defined stop and target, plus the key catalysts and r…
Sumitomo Corporation (SSUMY) is a classic trading-house exposure with a diversified asset base now showing signs of ROIC-friendly activity: strategic asset sales, consortium deals and a visible bid from major global allocators. At a $52.7B market cap, 13.5x P/E and a sub-2x P/B, the stock offers asymmetric upside if management uses recent monetizat…
Upstream Bio (UPB) is a clinical-stage biotech developing verekitug, a first-in-class TSLP receptor antagonist targeting severe respiratory inflammatory diseases. Recent Phase 2 data in CRSwNP and near-term regulatory interactions for Phase 3 in asthma and CRSwNP create concrete catalysts. The stock has reset from its $33.68 52-week high to about $…
Cintas (CTAS) runs a high-margin, recurring-revenue business with strong free cash flow, superior ROE, and modest leverage. The stock is trading near $173 while fundamentals and cash generation argue for upside toward $200 within the next ~45 trading days. I’m upgrading to a Buy and laying out an actionable entry, stop, and target with clear risk c…
Oak Valley Bancorp (OVLY) reported higher provisions that weighed on sequential earnings, but the underlying balance sheet — $2.01B in assets, ~$201.6M in cash, negligible leverage and NPA of 0.23% — argues this is a provisioning hiccup, not a credit-cycle problem. At $33.40 the stock trades at ~11.4x P/E with a 2.05% yield and 1.34x P/B. Trade ide…
Dell reported a blowout quarter with $43.84B revenue, $16.1B AI revenue and a $51.3B AI server backlog. Momentum is powerful but stretched; this trade targets a mid-term run while respecting an overbought setup and supply/price risks.
First Trust Large Cap Growth AlphaDEX Fund (FTC) is trading at a fresh 52-week high with bullish technical momentum, a tight short-interest profile and a market-cap of roughly $1.36B. This trade idea proposes a mid-term (45 trading days) long with strict risk controls to capture further upside as growth leadership extends.
SentinelOne plunged on Q1 results and layoff headlines, but the pullback overstates the danger. Revenue guidance of $1.195-$1.205B, positive adjusted EPS, an EV/sales near 6x, and improving free cash flow create a favorable backdrop for a disciplined long trade. This idea lays out entry, stop, target, horizon and the scenarios that would change the…
AST SpaceMobile is trading after a sharp retail-fueled run that pushed the stock from a 52-week low of $22.47 to a recent high near $133.86. With sector ETFs swelling, a SpaceX IPO heating up investor interest, and telco partnerships beginning to show commercial cadence, this trade backs continued multiple expansion and execution over the next 180 …
Alcoa (AA) has sprinted from a $25.83 52-week low to a new 52-week high of $76.78, driven by a raw-material supply shock and rising aluminum prices. Fundamentals remain mixed after a Q1 miss, but valuation, cash generation and a favorable technical setup support a disciplined long trade. Entry $76.10, stop $68.00, target $92.00 over a long-term (18…
Synopsys reported a Q2 beat and lifted full-year guidance, while cash generation and a healthy balance sheet paint a constructive fundamental backdrop. Shares have been consolidating below highs but price is coiling above the 50-day moving average and short interest is modest, creating an asymmetric risk-reward for a mid-term breakout trade.
Nano Labs (NA) is a micro-cap fabless chip designer with product lines that map directly to the needs of next-generation drones and edge-AI systems. At a $60M market cap, single-digit multiples, insider buying and a string of AI-related partnerships, the stock looks attractively priced for a momentum-driven long. This trade idea lays out an entry, …
Golconda Gold (GGGOF) is an OTC exploration/mining name trading around $1.94 with mixed technicals, shifting short interest and a narrative tied to a hoped-for Summit recommencement. This trade idea lays out a disciplined long entry ahead of potential project restart news and financing, balanced by a strict stop and acknowledgment of OTC execution …
Bakkt is repositioning from a niche crypto services provider to a payments/settlements infrastructure play after acquiring Distributed Technologies Research and leaning into stablecoin rails, tokenization and institutional custody. At a market cap near $490M and EV around $412M, the risk-reward looks attractive from $11 if you can tolerate executio…
Ally Financial (ALLY) is trading at a discount to book and earnings despite solid fundamentals: $13.1B market cap, trailing P/E ~10x, P/B ~0.84 and $1.1B in free cash flow. Macro headwinds in auto demand and tighter credit could pressure results near term, but the combination of yield-sensitive NIM expansion and a durable digital deposit franchise …
ICON (ICLR) suffered a sharp reset after an Audit Committee probe into revenue recognition for FY2023-2025, but the underlying CRO market and ICON's cash generation remain intact. The pullback offers a tactical entry for a mid-term swing trade while the company completes control remediation. Entry $136.84, target $165.00, stop $116.48. Expect reacc…
SIVEF (Sivers Semiconductors AB) shows strong technical momentum, rising short interest and heavy recent short selling — a combination that can produce sharp moves. This trade targets a measured double from $7.71 to $15.42 over a mid-to-long horizon while keeping risk defined with a $5.50 stop.
